ChRM2 Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is adenylate cyclase inhibition. Signaling promotes phospholipase C activity, leading to the release of inositol trisphosphate (IP3) ; this then triggers calcium ion release into the cytosol.
Synonyms
HM2; Muscarinic acetylcholine receptor M2; CHRM2
Gene ID
1129
Swiss Prot
P08172
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
381-466/466
Target
ChRM2
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human ChRM2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1129
Predicted Cross Reactivity
Pig, Chicken
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9421492-01 0.02 mg
Recombinant Human Endoplasmic reticulum-Golgi intermediate compartment protein 3
Ask
View Details 
MBS9421492-02 0.1 mg
Recombinant Human Endoplasmic reticulum-Golgi intermediate compartment protein 3
Ask
View Details 
MBS9421492-03 1 mg
Recombinant Human Endoplasmic reticulum-Golgi intermediate compartment protein 3
Ask
View Details MBS9421492-04 5x 1 mg
Recombinant Human Endoplasmic reticulum-Golgi intermediate compartment protein 3
Ask
View Details